The NHS will include an AI-powered triage tool in the NHS App in an attempt to cut waiting lists and improve care for ...

Roche's Genentech unit has forged an alliance with Astex, worth up to $515 million, to partner on a fragment-based drug ...

Novartis has reached a deal to buy Myricx Bio for up to $1.5 billion, giving it control of the London, UK, start-up's ...

Sir Chris Hoy has said he feels "very proud" when he hears of people taking part in the charity cycling event he set up last ...

Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been recommended for conditional approval in the EU. The EMA's human medicines ...

A series of pilot schemes set up by the UK in partnership with the pharma industry will test ways to get new medicines to ...

Scribe Therapeutics has become the latest biotech to announce plans to list on the Nasdaq, in what is being seen as a test of the appetite among investors for earlier-stage drug developers. The ...

Patients are being recruited into a clinical trial of two potential therapies for the Bundibugyo species of Ebola in the Democratic Republic of the Congo (DRC), according to the World Health ...

This week's collection of venture capital financings in the biotech arena includes rounds for Celea, Beeline, Flare, Lycia, and Telum. PureTech's Celea eyes phase 3 for IPF drug a ...

Once hailed as the “gold standard” for cancer management, though, MDTs are now under strain. Over the years, the number of referrals have gone up drastically and meeting times have increased to up to ...

Newron Pharmaceuticals thinks it may have reached an agreement with the FDA on a way to get the development of its schizophrenia candidate evenamide back on track, after it was placed under a clinical ...

Domenico wrote that drug pricing is remarkable for its "puzzling opacity," but added that it is "not necessary to unravel the ...